Cargando…

Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada

RATIONALE & OBJECTIVE: The benefit–risk profile of rivaroxaban versus warfarin for atrial fibrillation (AF) in patients with chronic kidney disease is uncertain. We compared rivaroxaban with warfarin across the range of kidney function in adults with AF. STUDY DESIGN: Multicenter retrospective c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ha, Jeffrey T., Scaria, Anish, Andrade, Jason, Badve, Sunil V., Birks, Peter, Bota, Sarah E., Campain, Anna, Djurdjev, Ognjenka, Garg, Amit X., Harel, Ziv, Hemmelgarn, Brenda, Hockham, Carinna, James, Matthew T., Jardine, Meg J., Lam, Dickson, Levin, Adeera, McArthur, Eric, Ravani, Pietro, Shao, Selena, Sood, Manish M., Tan, Zhi, Tangri, Navdeep, Whitlock, Reid, Gallagher, Martin, Jun, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363562/ https://www.ncbi.nlm.nih.gov/pubmed/37492112 http://dx.doi.org/10.1016/j.xkme.2023.100675

Ejemplares similares

Temporal Trends in Hemoglobin, Use of Erythropoiesis Stimulating Agents, and Major Clinical Outcomes in Incident Dialysis Patients in Canada
por: Canney, Mark, et al.
Publicado: (2021)

Perceptions of prognostic risks in chronic kidney disease: a national survey
por: Chiu, Helen H. L., et al.
Publicado: (2015)

Prescription Pattern of Cation Exchange Resins and Their Efficacy in Treating Chronic Hyperkalemia Among Patients With Chronic Kidney Diseases: Findings From a Population-Based Analysis in British Columbia, Canada
por: Atiquzzaman, Mohammad, et al.
Publicado: (2022)

Sex differences in chronic kidney disease prevalence in Asia: a systematic review and meta-analysis
por: Hockham, Carinna, et al.
Publicado: (2022)

Chronic kidney disease and support provided by home care services: a systematic review
por: Aydede, Sema K, et al.
Publicado: (2014)

Prior Cardiovascular Treatments—A Key Characteristic in Determining Medication Adherence After an Acute Myocardial Infarction
por: Campain, Anna, et al.
Publicado: (2022)

The Variability of Estimated Glomerular Filtration Rate Decline in Alport Syndrome
por: Langsford, David, et al.
Publicado: (2016)

Adverse changes in key chronic kidney disease care outcome metrics since the onset of the COVID-19 pandemic: experience from an established provincial renal program
por: Bevilacqua, Micheli, et al.
Publicado: (2022)

An overview of the British Columbia Glomerulonephritis network and registry: integrating knowledge generation and translation within a single framework
por: Barbour, Sean, et al.
Publicado: (2013)

Time to revisit the problem of CIN? The low incidence of acute kidney injury with and without contrast in hospitalized patients: an observational cohort study
por: Hemmett, Juliya, et al.
Publicado: (2015)

Cardiovascular risk is similar in patients with glomerulonephritis compared to other types of chronic kidney disease: a matched cohort study
por: Hutton, Holly L., et al.
Publicado: (2017)

A randomized control trial to assess the impact of vitamin D supplementation compared to placebo on vascular stiffness in chronic kidney disease patients
por: Levin, Adeera, et al.
Publicado: (2014)

Age and the eGFR-dependent risk for adverse clinical outcomes
por: Liu, Ping, et al.
Publicado: (2022)

Effectiveness of Latent TB Screening and Treatment in People Initiating Dialysis in British Columbia, Canada
por: Romanowski, Kamila, et al.
Publicado: (2020)

Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT)
por: Levin, Adeera, et al.
Publicado: (2013)

Sex Differences in CKD-Associated Mortality From 1990 to 2019: Data From the Global Burden of Disease Study
por: Hockham, Carinna, et al.
Publicado: (2022)

Investigating the Relationship Between Age and Kidney Failure in Adults With Category 4 Chronic Kidney Disease
por: Al-Wahsh, Huda, et al.
Publicado: (2020)

External validation and clinical utility of a prediction model for 6-month mortality in patients undergoing hemodialysis for end-stage kidney disease
por: Forzley, Brian, et al.
Publicado: (2017)

Systematic Evaluation of a Provincial Initiative to Improve Transition to Home Dialysis Therapies
por: Wang, Alice, et al.
Publicado: (2020)

Predicting kidney failure risk after acute kidney injury among people receiving nephrology clinic care
por: Sawhney, Simon, et al.
Publicado: (2018)

COVID-19 vaccine effectiveness in patients with non–dialysis-dependent chronic kidney diseases: findings from a population-based observational study from British Columbia, Canada
por: Atiquzzaman, Mohammad, et al.
Publicado: (2022)

Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis
por: Nitsch, Dorothea, et al.
Publicado: (2013)

Understanding the haplotypic diversity and distribution of malaria-protective β-globin mutations
por: Hockham, Carinna, et al.
Publicado: (2014)

Women’s representation as authors of retracted papers in the biomedical sciences
por: Pinho-Gomes, Ana-Catarina, et al.
Publicado: (2023)

Risk Factors for Prognosis in Patients With Severely Decreased GFR
por: Evans, Marie, et al.
Publicado: (2018)

EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study
por: Foote, Celine, et al.
Publicado: (2020)

COVID-19 Vaccine Effectiveness Among Patients With Maintenance Dialysis; Observations From Population Level Cohort Studies in 2 Large Canadian Provinces
por: Atiquzzaman, Mohammad, et al.
Publicado: (2023)

Understanding the contrasting spatial haplotype patterns of malaria-protective β-globin polymorphisms
por: Hockham, Carinna, et al.
Publicado: (2015)

Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected data
por: Zhang, Hongmei, et al.
Publicado: (2020)

Validation of Self-Reported Race in a Canadian Provincial Renal Administrative Database
por: Waheed, Aiza, et al.
Publicado: (2019)

Short‐Term Change in eGFR and Risk of Cardiovascular Events
por: Turin, Tanvir Chowdhury, et al.
Publicado: (2014)

The three-year incidence of major hemorrhage among older adults initiating chronic dialysis
por: Sood, Manish M, et al.
Publicado: (2014)

Women's representation in clinical trials of patients with chronic kidney disease
por: Pinho-Gomes, Ana-Catarina, et al.
Publicado: (2023)

Development and External Validation of a Machine Learning Model for Progression of CKD
por: Ferguson, Thomas, et al.
Publicado: (2022)

Risk Factors for Fracture in Patients with Coexisting Chronic Kidney Disease and Type 2 Diabetes: An Observational Analysis from the CREDENCE Trial
por: Young, Tamara K., et al.
Publicado: (2022)

Contextualising sex and gender research to improve women's health: An early- and mid-career researcher perspective
por: Hallam, Laura, et al.
Publicado: (2022)

Improved estimation of glomerular filtration rate (GFR) by comparison of eGFR(cystatin C) and eGFR(creatinine)
por: Grubb, Anders, et al.
Publicado: (2012)

Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA(1c), disease duration and treatment intensity: results from the CANVAS Program
por: Young, Tamara K., et al.
Publicado: (2021)

Safety of add-on sulfonylurea therapy in patients with type 2 diabetes using metformin: a population-based real-world study
por: Hougen, Ingrid, et al.
Publicado: (2021)

Findings of Sodium-Glucose Cotransporter-2 Inhibitor Kidney Outcome Trials Applied to a Canadian Chronic Kidney Disease Population: A Retrospective Cohort Study
por: Yi, Tae Won, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vajodtus1h3f4cho2r7dp1d7v4